Recall of Zocor 80mg Dose Should Have Been Issued: Consumer Group
The FDA did not go far enough in restricting the use of high doses of the cholesterol drug Zocor, and approval for 80 mg simvastatin medications should have been withdrawn…
Tag Archives: Vytorin
-
-
Zocor Muscle Injury Risk Leads to FDA Warning Over High Dose Simvastatin
Federal drug safety reviewers are calling for limits use of the highest dose of the cholesterol drug simvastatin, which is most commonly marketed as Zocor, saying that the 80 mg…
-
Zocor Rhabdomyolysis Muscle Injury Warning Issued by FDA
High doses of the cholesterol-fighting drug Zocor can increase the risk of rhabdomyolysis, a serious and potentially fatal muscle disease, according to federal regulators.
-
Vytorin Cancer Link Not Seen by FDA
Federal regulators indicate that it is unlikely that the cholesterol drug Vytorin causes cancer, despite a clinical study in 2008 which raised potential Vytorin cancer concerns.
-
Zetia, Vytorin Problems Continue With Latest Study
In the latest blow to popular cholesterol drugs Vytorin and Zetia, new research indicates that the medications may be less effective than older drugs in reducing the buildup of cholesterol…
-
Zetia and Vytorin Side Effects Not Linked to Cancer According to Study
Despite reports that emerged last year linking side effects of Vytorin and Zetia to an increased incidence of cancer, a new study suggests that the cholesterol drugs are not associated…
-
FDA Indicates Vytorin and Other Cholesterol Drugs Should Not Be Stopped
Despite concerns which emerged last year about whether Vytorin provides any benefits over cheaper, generic alternatives, the FDA indicated last week that their review of available data does not suggest…
-
Vytorin Class Action Lawsuits Mount as Justice Deptartment Investigates
Merck & Co. and Schering-Plough Corp. currently face around 140 Vytorin class action lawsuits involving their once-popular cholesterol drug, which has been shown to provide no medical benefits over cheaper…
-
New Haven Connecticut Plans to File Vytorin Lawsuit
The city of New Haven, Connecticut, has indicated that they plan to file a Vytorin lawsuit against Merck and Schering-Plough to recover over $400,000 in prescription costs paid for employees…
-
Researcher Claims “No Credible Evidence” of Vytorin Cancer Side Effects
In response to concerns about a potential link between Vytorin and cancer, the FDA has initiated a safety review and members of Congress have requested additional information about the potential…
